With full membership, watch our educational and editorial videos, search the site, receive our newsletters, join discussions, download slides and much more.
Address practice gaps and evaluate evidence-based data regarding the safety and efficacy of existing and novel pharmacotherapies and pharmacomechanical techniques in VTE.
Discuss evidence-based data and address an array of issues involving prevention and treatment of venous thromboembolism in patients in many settings and at various levels of risk.
Dr. Becker, along with Drs. Gibson, Wallentin, and Wiviott, explore the strengths and weaknesses of contemporary antiplatelet therapy in patients status post acute coronary syndrome
Drs. Becker and Weitz lead a discussion with Drs. Agnelli, Ezekowitz, Heit, and Mahaffey on the envisioned improvements in care of patients with thromboembolic disease
Discuss evidence-based data and address an array of issues involving prevention and treatment of venous thromboembolism in patients in many settings and at various levels of risk
Dr. Anne Peters and colleagues discuss strategies to improve partnerships with patients from culturally diverse backgrounds who have type 2 diabetes and CVD.
Review the atherothrombotic process, address the unmet needs of secondary prevention, and discuss approaches aimed at reducing residual risk in coronary heart disease to better manage patients with acute coronary syndromes.
Genetic findings that affect the course of diseases have been increasing geometrically. Cardiology is one of the specialties that has benefited from recent discoveries. David Danar, MD, Scientific Director, MedscapeCME, interviewed John P. Kane, MS, MD, PhD, about the role of genetics in determining the risk for and management of heart disease.
Show all
Collapse